Prediction Case File
YouTubeEvaluation Complete

PLASMA XPL PRICE PREDICTION 2025

1 extracted signal · 1 resolved · 0 still active

Cilinix Crypto profile imageCilinix Crypto30 Sept 2025, 12:31 UTC
Video preview for PLASMA XPL PRICE PREDICTION 2025
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
1
Canonical correct result
Failed
0
Canonical failed result
Resolved success
100%
Open and excluded signals omitted
Source overview

AI-generated source summary

The analysis covers the XPLUSDT pair. The analyst has been accurate on predicting the moves. Yesterday the price was around 1.30. The analyst is waiting for a strong support level. The analyst states he needs to see bullish divergence and volume. At 7 day rolling VWAP he saw no leverage increase. The analyst points out at 30 day rolling VWAP a strong level at 1.125. The analyst thinks the bottom is coming close. Analyst points that from the top the pair is down 32%. The analyst expects local support at 1.07 and 1.00.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

Cilinix Crypto

Tracked signals
1195
Historical success
42.8%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.